A new preliminary study -- based on a small sample -- has suggested that people previously infected by the Covid-19 variant identified in South Africa may have better immunity against other coronavirus mutations, experts said Wednesday.

Study suggests South Africa variant could offer better immunity

South Africa will continue with the planned phase 1 vaccination using the Johnson & Johnson, Health Minister, Zweli Mkhize said today. “Given the outcomes of the efficacy studies, the Department of Health will continue with the planned phase 1 vaccination using the Johnson & Johnson vaccine instead of the AstraZeneca vaccine,” the Minister said in a virtual briefing on Wednesday morning.

South Africa to proceed with planned phase 1 vaccination using J&J

south-africa-covid-strain

South Africa Covid Strain, News on South Africa Covid Strain, stories on South Africa Covid Strain, articles on South Africa Covid Strain, South Africa Covid Strain stories at Wion, South Africa Covid Strain news, South Africa Covid Strain latest news

south africa-covid-strain

Study suggests South Africa variant could offer better immunity

South Africa to proceed with planned phase 1 vaccination using J&J